Efficient and precise genetic engineering in livestock such as cattle holds great promise in agriculture and biomedicine. However, techniques that generate pluripotent stem cells, as well as reliable tools for gene targeting in livestock, are still inefficient, and thus not routinely used. Here, we report highly efficient gene targeting in the bovine genome using bovine pluripotent cells and clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 nuclease. First, we generate induced pluripotent stem cells (iPSCs) from bovine somatic fibroblasts by the ectopic expression of yamanaka factors and GSK3β and MEK inhibitor (2i) treatment. We observed that these bovine iPSCs are highly similar to naïve pluripotent stem cells with regard to gene expression and developmental potential in teratomas. Moreover, CRISPR/Cas9 nuclease, which was specific for the bovine NANOG locus, showed highly efficient editing of the bovine genome in bovine iPSCs and embryos. To conclude, CRISPR/Cas9 nuclease-mediated homologous recombination targeting in bovine pluripotent cells is an efficient gene editing method that can be used to generate transgenic livestock in the future.
Get full access to this article
View all access options for this article.
References
1.
AllenMS, BradfordBJ and HarvatineKJ. (2005). The cow as a model to study food intake regulation. Annu Rev Nutr, 25:523–547.
2.
NiemannH and KuesW. (2000). Transgenic livestock: premises and promises. Anim Reprod Sci, 60:277–293.
3.
NiemannH and KuesWA. (2003). Application of transgenesis in livestock for agriculture and biomedicine. Anim Reprod Sci, 79:291–317.
4.
RudolphNS. (1999). Biopharmaceutical production in transgenic livestock. Trends Biotechnol, 17:367–374.
5.
WallR. (1996). Transgenic livestock: progress and prospects for the future. Theriogenology, 45:57–68.
6.
GandolfiF, PennarossaG, MaffeiS and BreviniT. (2012). Why is it so difficult to derive pluripotent stem cells in domestic ungulates?. Reprod Domest Anim, 47:11–17.
7.
KeeferC, PantD, Blomberg and TalbotL. (2007). Challenges and prospects for the establishment of embryonic stem cell lines of domesticated ungulates. Anim Reprod Sci, 98:147–168.
8.
WilmutI, BeaujeanN, De SousaP, DinnyesA, KingT, PatersonL, WellsD and YoungL. (2002). Somatic cell nuclear transfer. Nature, 419:583–587.
9.
RenardJ, ZhouQ, LeBourhisD, Chavatte-PalmerP, HueI, HeymanY and VignonX. (2002). Nuclear transfer technologies: between successes and doubts. Theriogenology, 57:203–222.
TakahashiK and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
12.
LiW, WeiW, ZhuS, ZhuJ, ShiY, LinT, HaoE, HayekA, DengH and DingS. (2009). Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell, 4:16–19.
13.
EstebanMA, XuJ, YangJ, PengM, QinD, LiW, JiangZ, ChenJ, DengK and ZhongM. (2009). Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem, 284:17634–17640.
14.
LiuH, ZhuF, YongJ, ZhangP, HouP, LiH, JiangW, CaiJ, LiuM and CuiK. (2008). Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell, 3:587–590.
15.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
16.
RobintonDA and DaleyGQ. (2012). The promise of induced pluripotent stem cells in research and therapy. Nature, 481:295–305.
17.
HannaJ, ChengAW, SahaK, KimJ, LengnerCJ, SoldnerF, CassadyJP, MuffatJ, CareyBW and JaenischR. (2010). Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A, 107:9222–9227.
18.
GafniO, WeinbergerL, MansourAA, ManorYS, ChomskyE, Ben-YosefD, KalmaY, ViukovS, MazaI, et al. (2013). Derivation of novel human ground state naive pluripotent stem cells. Nature, 504:282–286.
19.
NicholsJ and SmithA. (2009). Naive and primed pluripotent states. Cell Stem Cell, 4:487–492.
20.
HannaJH, SahaK and JaenischR. (2010). Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell, 143:508–525.
21.
HorvathP and BarrangouR. (2010). CRISPR/Cas, the immune system of bacteria and archaea. Science, 327:167–170.
22.
CongL, RanFA, CoxD, LinS, BarrettoR, HabibN, HsuPD, WuX, JiangW and MarraffiniLA. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science, 339:819–823.
23.
RanFA, HsuPD, WrightJ, AgarwalaV, ScottDA and ZhangF. (2013). Genome engineering using the CRISPR-Cas9 system. Nat Protoc, 8:2281–2308.
24.
BassettAR, TibbitC, PontingCP and LiuJ-L. (2013). Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep, 4:220–228.
25.
FriedlandAE, TzurYB, EsveltKM, ColaiácovoMP, ChurchGM and CalarcoJA. (2013). Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods, 10:741–743.
26.
WangH, YangH, ShivalilaCS, DawlatyMM, ChengAW, ZhangF and JaenischR. (2013). One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell, 153:910–918.
27.
GuschinDY, WaiteAJ, KatibahGE, MillerJC, HolmesMC and RebarEJ. (2010). A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol, 649:247–256.
28.
RosenkransCF and FirstNL. (1994). Effect of free amino acids and vitamins on cleavage and developmental rate of bovine zygotes in vitro. J Anim Sci, 72:434–437.
29.
MaliP, AachJ, StrangesPB, EsveltKM, MoosburnerM, KosuriS, YangL and ChurchGM. (2013). CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol, 31:833–838.
30.
SumerH, LiuJ, Malaver-OrtegaL, LimML, KhodadadiK and VermaPJ. (2011). NANOG is a key factor for induction of pluripotency in bovine adult fibroblasts. J Anim Sci, 89:2708–2716.
31.
YingQ-L, WrayJ, NicholsJ, Batlle-MoreraL, DobleB, WoodgettJ, CohenP and SmithA. (2008). The ground state of embryonic stem cell self-renewal. Nature, 453:519–523.
32.
HuangfuD, MaehrR, GuoW, EijkelenboomA, SnitowM, ChenAE and MeltonDA. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol, 26:795–797.
33.
LohY-H, WuQ, ChewJ-L, VegaVB, ZhangW, ChenX, BourqueG, GeorgeJ, LeongB and LiuJ. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet, 38:431–440.
34.
ChambersI, ColbyD, RobertsonM, NicholsJ, LeeS, TweedieS and SmithA. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell, 113:643–655.
35.
GajT, GersbachCA and BarbasCFIII. (2013). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol, 31:397–405.
36.
WheelerM, WaltersE and ClarkS. (2003). Transgenic animals in biomedicine and agriculture: outlook for the future. Anim Reprod Sci, 79:265–289.
37.
WheelerMB. (2007). Agricultural applications for transgenic livestock. Trends Biotechnol, 25:204–210.
38.
BondioliK, WesthusinM and LooneyC. (1990). Production of identical bovine offspring by nuclear transfer. Theriogenology, 33:165–174.
39.
SilvaJ, BarrandonO, NicholsJ, KawaguchiJ, TheunissenTW and SmithA. (2008). Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol, 6:e253
40.
GuoG, YangJ, NicholsJ, HallJS, EyresI, MansfieldW and SmithA. (2009). Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development, 136:1063–1069.
41.
CarlsonDF, TanW, LillicoSG, StverakovaD, ProudfootC, ChristianM, VoytasDF, LongCR, WhitelawCBA and FahrenkrugSC. (2012). Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci U S A, 109:17382–17387.
42.
SakumaT, HosoiS, WoltjenK, Ki Suzuki, KashiwagiK, WadaH, OchiaiH, MiyamotoT, KawaiN and SasakuraY. (2013). Efficient TALEN construction and evaluation methods for human cell and animal applications. Genes Cells, 18:315–326.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
